1 study found for:    NCT00625846
Show Display Options
Rank Status Study
1 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer;   Stage III Follicular Thyroid Cancer;   Stage III Papillary Thyroid Cancer;   Stage IV Follicular Thyroid Cancer;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Papillary Thyroid Cancer;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Papillary Thyroid Cancer;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Papillary Thyroid Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: pazopanib hydrochloride;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years